1. Risk of psychological effects should not preclude corticosteroid use

   Review 08 February 2013 Pages: 2 - 2

2. Risk of severe adverse skin reactions to Fansidar (Rm) is acceptable

   Incidence study 08 February 2013 Pages: 2 - 2

3. Agents to avoid to reduce risk of febrile convulsions

   Comment 08 February 2013 Pages: 3 - 3

4. Changing pattern of drug-induced scalded skin syndrome in France

   Incidence study 08 February 2013 Pages: 3 - 3

5. Urinary metabolites may predict deferoxamine sensitivity

   Clinical study 08 February 2013 Pages: 3 - 3

6. Acenocoumarol

   Incidence study 08 February 2013 Pages: 4 - 4

7. Cardiovascular effects of psychostimulants not a problem in children

   Review 08 February 2013 Pages: 4 - 4

8. Drug hypersensitivity more common in Chinese patients with SLE

   Incidence study 08 February 2013 Pages: 4 - 4

9. Acenocoumarol interaction

   Case report 08 February 2013 Pages: 5 - 5

10. Allopurinol

    Case reports 08 February 2013 Pages: 5 - 5

11. Amiodarone

    Incidence study 08 February 2013 Pages: 5 - 5

12. Anticoagulants

    Incidence study 08 February 2013 Pages: 5 - 5

13. Anticoagulants

    Case reports 08 February 2013 Pages: 5 - 5

14. Antineoplastics

    Incidence study 08 February 2013 Pages: 5 - 5

15. Antipsychotics

    Incidence study 08 February 2013 Pages: 5 - 5

16. Benzocaine

    Case report 08 February 2013 Pages: 5 - 5

17. Botulinum toxin

    Case report 08 February 2013 Pages: 5 - 5

18. Carbamazepine

    Case report 08 February 2013 Pages: 6 - 6

19. Carbamazepine overdose

    Case report 08 February 2013 Pages: 6 - 6

20. Ciprofloxacin

    Case reports 08 February 2013 Pages: 6 - 6

21. Clebopride

    Case report 08 February 2013 Pages: 6 - 6

22. Clebopride/aprindine/buformin

    Case reports 08 February 2013 Pages: 6 - 6

23. Corticosteroids

    Case reports 08 February 2013 Pages: 6 - 6

24. Corticotrophin

    Incidence study 08 February 2013 Pages: 6 - 6

25. Cyclobenzaprine

    Case reports 08 February 2013 Pages: 7 - 7

26. Cytarabine

    Case report 08 February 2013 Pages: 7 - 7

27. Danazol

    Case report 08 February 2013 Pages: 7 - 7

28. Deferoxamine

    Case report 08 February 2013 Pages: 7 - 7

29. Demeclocycline

    Case report 08 February 2013 Pages: 7 - 7

30. Digoxin

    Incidence study 08 February 2013 Pages: 7 - 7

31. Dipyridamole

    Incidence study 08 February 2013 Pages: 7 - 7

32. Dipyridamole

    Case reports 08 February 2013 Pages: 7 - 7

33. Diuretics

    Review 08 February 2013 Pages: 8 - 8

34. Etoposide

    Incidence study 08 February 2013 Pages: 8 - 8

35. Etretinate

    Case report 08 February 2013 Pages: 8 - 8

36. Fluorouracil + levamisole

    Case report 08 February 2013 Pages: 8 - 8

37. Gentamicin/tobramycin

    Incidence study 08 February 2013 Pages: 8 - 8

38. Heparin

    Case report 08 February 2013 Pages: 9 - 9

39. Hepatitis B vaccine recombinant

    Case report 08 February 2013 Pages: 9 - 9

40. Herbal medicine

    Case report 08 February 2013 Pages: 9 - 9

41. Indomethacin

    Incidence study 08 February 2013 Pages: 9 - 9

42. Interferon alpha

    Case report 08 February 2013 Pages: 10 - 10

43. Interferon beta interaction

    Clinical study 08 February 2013 Pages: 10 - 10

44. Ketamine

    Incidence study 08 February 2013 Pages: 10 - 10

45. Ketoconazole

    Case report 08 February 2013 Pages: 10 - 10

46. Ketorolac

    Case report 08 February 2013 Pages: 10 - 10

47. Ketorolac

    Case report 08 February 2013 Pages: 12 - 12

48. Leuprorelin

    Incidence study 08 February 2013 Pages: 12 - 12

49. Lisinopril

    Case report 08 February 2013 Pages: 12 - 12

50. Methotrexate

    Case report 08 February 2013 Pages: 12 - 12